NMIBC treatment update: medac plans stable production of BCG-medac in the medium term
Wedel, Germany (2023-03-10) Over the course of 2023 and 2024, medac GmbH plans to be in a position to successively supply all markets with an existing BCG-medac marketing authorisation […]